High frequency of circulating non-classical monocytes is associated with stable remission in relapsing-remitting multiple sclerosis-Reference-Cited by-同舟云学术

High frequency of circulating non-classical monocytes is associated with stable remission in relapsing-remitting multiple sclerosis

Published:2024-03-27 Issue:3 Volume:47 Page:151-165
ISSN:2578-5826
Container-title:Immunological Medicine
language:en
Short-container-title:Immunological Medicine

Author:

Minote Misako¹²^ORCID,Sato Wakiro¹³⁴^ORCID,Kimura Kimitoshi¹²^ORCID,Kimura Atsuko¹^ORCID,Lin Youwei¹³⁵^ORCID,Okamoto Tomoko³⁵^ORCID,Takahashi Ryosuke²^ORCID,Yamamura Takashi¹³^ORCID

Affiliation:

1. Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Japan

2. Department of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan

3. Multiple Sclerosis Center, National Center of Neurology and Psychiatry, Kodaira, Japan

4. Section of Research and Development Strategy, Translational Medical Center, National Center of Neurology and Psychiatry, Kodaira, Japan

5. Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Japan

Funder

Practical Research Project for Rare/Intractable Diseases from Japan Agency for Medical Research and development, AMED

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/25785826.2024.2331271

Reference49 articles.

1. Multiple sclerosis: Neuroimmune crosstalk and therapeutic targeting

2. Is it time to target no evident disease activity (NEDA) in multiple sclerosis?

3. “No evident disease activity”: The use of combined assessments in the management of patients with multiple sclerosis

4. Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort

5. Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1b